Wednesday, May 13, 2026

biopharmaceutical

May 20, 2024

AstraZeneca to manufacture cancer killer in Singapore

AstraZeneca says it will invest $1.5 billion in building a manufacturing facility in Singapore for antibody-drug conjugates.

AstraZeneca vaccine